Cargando…
Chemotherapy Use and Survival Among Young and Middle-Aged Patients With Gastric Cancer
INTRODUCTION: Treatments for young patients with gastric cancer (GC) remain poorly defined, and their effects on survival are uncertain. We aimed to investigate the receipt of chemotherapy by age category (18–49, 50–64, and 65–85 years) and explore whether age differences in chemotherapy matched sur...
Autores principales: | Jiang, Yuming, Xie, Jingjing, Huang, Weicai, Chen, Hao, Xi, Sujuan, Li, Tuanjie, Chen, Chuanli, Sun, Zepang, Hu, Yanfeng, Liu, Wei, Yu, Jiang, Zhou, Zhiwei, Cai, Shirong, Li, Guoxin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556366/ https://www.ncbi.nlm.nih.gov/pubmed/33108125 http://dx.doi.org/10.14309/ctg.0000000000000253 |
Ejemplares similares
-
Young age increases risk for lymph node positivity in gastric cancer: A Chinese multi-institutional database and US SEER database study
por: Jiang, Yuming, et al.
Publicado: (2020) -
Radiomics Signature on Computed Tomography Imaging: Association With Lymph Node Metastasis in Patients With Gastric Cancer
por: Jiang, Yuming, et al.
Publicado: (2019) -
Radiomic signature of( 18)F fluorodeoxyglucose PET/CT for prediction of gastric cancer survival and chemotherapeutic benefits
por: Jiang, Yuming, et al.
Publicado: (2018) -
Liver Metastases in Newly Diagnosed Gastric Cancer: A Population-Based Study from SEER
por: Sun, Zepang, et al.
Publicado: (2019) -
Radiomics signature of computed tomography imaging for prediction of survival and chemotherapeutic benefits in gastric cancer
por: Jiang, Yuming, et al.
Publicado: (2018)